trending Market Intelligence /marketintelligence/en/news-insights/trending/qaesafgjncxhfogirpel0g2 content esgSubNav
In This List

Bioxyne director resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bioxyne director resigns

Bioxyne Ltd. said Peter French resigned from its board to pursue a senior management role at an international biotechnology company.

French will remain available to the company as a consultant.

Sydney-based Bioxyne provides consumer dietary supplements and dairy foods based on its proprietary probiotic strain.